GlaxoSmithKline
UEI: CR4UZS5SKL15
OVERVIEW
Name
GlaxoSmithKline
Alternative Names
GSK
Awardee Type
Parent
(15 children)
Website
Ownership
Publicly Traded (NYSE:GSK)
Most Recent Award
Dec. 31, 2022
Calculating
FEDERAL AWARD ANALYSIS
Historical Federal Obligations Awarded to GlaxoSmithKline
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
ACTIVE GSA SCHEDULES
- Glaxosmithkline
- PoP: 7/31/22 - 7/31/27
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $8,132,966
- Viiv Healthcare Company
- PoP: 8/14/21 - 8/14/26
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Glaxosmithkline Consumer Healthcare, L.P
- PoP: 6/30/18 - 9/30/23
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Tesaro
- PoP: 5/31/16 - 6/14/21 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Viiv Healthcare Company
- PoP: 5/31/13 - 8/14/21 (Ended)
- Glaxosmithkline
- PoP: 9/29/12 - 8/1/22 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $20,131,000